|

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

RECRUITINGPhase 4Sponsored by Ain Shams University
Actively Recruiting
PhasePhase 4
SponsorAin Shams University
Started2025-08-01
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07268586

Summary

People with acute inferior wall myocardial infarction will be given an intravenous drug called atropine that increases the heart rate to check if it prevents heart rhythm disturbances during performing coronary intervention

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Acute inferior ST elevation myocardial infarction

Exclusion Criteria:

* Execution of rescur percutaneous coronary intervention after thrombolysis
* Mechanical complications or no reflow or spontaneous reperfusion.
* Prior implantation of permanent or temporary pacemakers
* History of bradycardia, hypotension or ventricular tachycardia with a definitive cause (unrelated to the disease under study)
* Prior coronary artery bypass graft surgery
* Atropine contraindications Unwillingness to participate in the

Conditions2

Heart DiseaseMyocardial Infarction

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.